Diagnosis of HIV Infection | p. 1 |
Establishing the Diagnosis of HIV Infection | p. 3 |
Antiretroviral Therapy | p. 21 |
Zidovudine | p. 23 |
Didanosine | p. 39 |
Zalcitabine | p. 57 |
Stavudine | p. 66 |
Lamivudine | p. 84 |
Emtricitabine | p. 102 |
Abacavir | p. 110 |
Delavirdine | p. 122 |
Nevirapine | p. 134 |
Efavirenz | p. 145 |
Saquinavir | p. 157 |
Ritonavir | p. 174 |
Indinavir | p. 190 |
Nelfinavir | p. 212 |
Amprenavir | p. 225 |
Lopinavir | p. 236 |
Tenofovir Disoproxil Fumarate | p. 245 |
Inhibitors of HIV Attachment and Fusion | p. 252 |
New Drugs in Development | p. 263 |
Immune-Based Therapies | p. 273 |
General Immune-Based Therapies in the Management of HIV-Infected Patients | p. 275 |
Approach to HIV Antigen-Specific Immune Enhancement | p. 284 |
Other Therapies Including Alternative Therapies | p. 295 |
Complementary and Alternative Therapies | p. 297 |
Strategies for Managing Antiretroviral Therapies | p. 311 |
Acute HIV Infection | p. 313 |
Occupational and Nonoccupational Exposure Management | p. 327 |
HIV Resistance Testing in Clinical Practice | p. 347 |
Strategic Use of Antiretroviral Therapy | p. 359 |
Managing Pregnant Patients | p. 381 |
Diagnosis, Therapy, and Prevention of Opportunistic Processes | p. 401 |
Pneumocystosis | p. 403 |
Toxoplasmosis | p. 419 |
Cryptosporidium, Isospora, and Cyclospora Infections | p. 438 |
Microsporidiosis | p. 445 |
Mycobacterium Tuberculosis Infection | p. 459 |
Mycobacterium avium Complex and Other Atypical Mycobacterial Infections | p. 475 |
Bartonellosis | p. 491 |
Cryptococcosis | p. 498 |
Histoplasmosis | p. 511 |
Coccidioidomycosis | p. 522 |
Candidiasis | p. 531 |
Mycoses Caused by Moulds | p. 543 |
Herpes Simplex Virus Infections | p. 555 |
Varicella-Zoster Virus Infections | p. 564 |
Cytomegalovirus Disease | p. 582 |
Human Herpesvirus-6 and Herpesvirus-7 Infections | p. 604 |
Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus | p. 613 |
Hepatitis Viruses | p. 625 |
Sexually Transmitted Human Papillomavirus Infection | p. 640 |
JC Virus Neurologic Infection | p. 666 |
Sexually Transmitted Diseases | p. 674 |
Kaposi's Sarcoma | p. 682 |
Non-Hodgkin's Lymphoma | p. 696 |
Primary Care: Daily Management of HIV-Infected Patients | p. 706 |
Approach to Specific Syndromes | p. 721 |
Wasting Syndrome | p. 723 |
Neurologic Disease | p. 737 |
Dermatologic Disease | p. 758 |
Oropharyngeal Disease | p. 776 |
Ophthalmologic Disease | p. 785 |
Hematologic Disease | p. 801 |
Cardiac Disease | p. 814 |
Repiratory Disease | p. 827 |
Renal Disease | p. 853 |
Diabetes, Insulin Resistance, Lipid Disorders, and Fat Redistribution Syndromes | p. 862 |
Adrenal, Gonadal, and Thyroid Disorders | p. 874 |
Diseases of the Esophagus, Stomach, and Bowel | p. 885 |
Hepatic and Hepatobiliary Diseases | p. 902 |
Drug Administration and Interactions | p. 921 |
Drug Administration and Interactions | p. 923 |
AIDS-Related Medications | p. 940 |
HIV/AIDS-Related Internet Resources | p. 971 |
Antiretroviral Adult Dosage Guidelines | p. 977 |
Index | p. 981 |
Table of Contents provided by Syndetics. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.